International Medical News Group LLC

SHERPA: Unknown

People

  1. Lichtman
    Lichtman

Groups

  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Gynecologic Medicine Service (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. GSK Faculty (1)
  6. Melanoma and Immunotherapeutics Service (1)
Search Within
Formats
  1. Journal Article (40)
Groups
  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Gynecologic Medicine Service (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. GSK Faculty (1)
  6. Melanoma and Immunotherapeutics Service (1)
People
  1. Stuart Lichtman (38)
  2. Jedd Wolchok (1)
  3. Karyn Goodman (1)
  4. Paul Chapman (1)
Years
  1. 2015 (1)
  2. 2012 (1)
  3. 2011 (4)
  4. 2010 (4)
  5. 2007 (9)
  6. 2006 (9)

More Years

Publications
  1. The Oncology Report (40)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Age is not a valid exclusion criterion for FOLFOX4 treatment - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • TREE trial confirms bevacizumab benefit in untreated metastatic colorectal cancer - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • FOLFOX treatment of metastatic colorectal cancer rescues initially unresectable patients - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • Cetuximab enhances responses in metastatic colorectal cancer - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • Bevacizumab does not preclude metastasectomy for metastatic CRC - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • PTK787/ZK222584 improves PFS when joined with FOLFOX4 - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • UGTIAI status cannot predict treatment benefit in advanced colorectal cancer - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy after resection of CRC metastases improves outcome - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2006)

    Fulltext@MSK | Save
  • Capecitabine better than bolus 5-FLU/leucovorin as adjuvant therapy for Dukes' C cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Bevacizumab can be safely combined with FOLFOX or XELOX
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save

    • International Medical News Group LLC – authorized name for: